EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

IκBζ target genes in chronic lymphocytic leukemia

Ilenia Sana, Miriam Meloni, Francesca Genova, Maria Elena Mantione, Anna Sofia Tascini, Ettore Zapparoli, Greta Carbone Faccin, Dimitra Paschaloudi, Martina Del Nero, Chiara Lenzi, Pamela Ranghetti, Eleonora Perotta und 3 weitere

iScience · 2026-11 · 29 (11) · 117828

DOI: 10.1016/j.isci.2026.117828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift iScience, 2026-11. Verfasst von Ilenia Sana und 14 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Cancer Center, IRCCS Ospedale San Raffaele, Milano, Italy. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IκBζ, an atypical IκB protein induced downstream of Toll-like receptor (TLR) signaling, is pivotal in orchestrating inflammatory responses and modulating inflammation-associated B cell malignancies. However, the transcriptional and epigenetic programs regulated by IκBζ in both normal and malignant B cells remain poorly described. Here, we analyzed chronic lymphocytic leukemia (CLL) cells by epigenomic profiling to dissect the molecular function of IκBζ in leukemia. In primary human B cells and CLL samples, chromatin immunoprecipitation sequencing (ChIP-seq) and cleavage under targets and tagmentation (CUT&Tag) analyses delineated a comprehensive genome-wide landscape of IκBζ binding sites. Key genes, including NFKB2, BATF, and FOXP1, gained IκBζ binding after TLR stimulation in both CLL and B cells, whereas CXCR5 was mainly bound in CLL cells. Pharmacological or genetic inhibition of IκBζ signaling disrupted the induction of these molecules, highlighting its potential role as a central transcriptional tuner that integrates TLR-mediated inflammatory pathways with B cell receptor (BCR) signaling and migration.

Schlagwörter

Stichwörter der Autor:innen

CLLINAPIκBζMAILNFKBIZTLRToll-like receptorschronic lymphocytic leukemia

Autor:innen und Institutionen

  • Comprehensive Cancer Center, IRCCS Ospedale San Raffaele, Milano, Italy.
  • Università Vita-Salute San Raffaele, Milano, Italy.
  • Center for Omics Sciences, IRCCS Ospedale San Raffaele, Milano, Italy.

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Sana, I., Meloni, M., Genova, F., Mantione, M. E., Tascini, A. S., Zapparoli, E., Carbone Faccin, G., Paschaloudi, D., Del Nero, M., Lenzi, C., Ranghetti, P., Perotta, E., Scarfò, L., Ghia, P., & Muzio, M. (2026). IκBζ target genes in chronic lymphocytic leukemia. iScience, 29(11), 117828. https://doi.org/10.1016/j.isci.2026.117828

Vancouver

Sana I, Meloni M, Genova F, Mantione ME, Tascini AS, Zapparoli E, et al. IκBζ target genes in chronic lymphocytic leukemia. iScience. 2026;29(11):117828. doi:10.1016/j.isci.2026.117828

BibTeX
@article{Sana2026,
  author = {Sana, Ilenia and Meloni, Miriam and Genova, Francesca and Mantione, Maria Elena and Tascini, Anna Sofia and Zapparoli, Ettore and Carbone Faccin, Greta and Paschaloudi, Dimitra and Del Nero, Martina and Lenzi, Chiara and Ranghetti, Pamela and Perotta, Eleonora and Scarfò, Lydia and Ghia, Paolo and Muzio, Marta},
  title = {IκBζ target genes in chronic lymphocytic leukemia},
  journal = {iScience},
  year = {2026},
  volume = {29},
  number = {11},
  pages = {117828},
  doi = {10.1016/j.isci.2026.117828}
}
Kostenlos starten →